2-210591913-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001875.5(CPS1):​c.1030A>G​(p.Thr344Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.567 in 1,610,050 control chromosomes in the GnomAD database, including 260,102 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T344S) has been classified as Benign.

Frequency

Genomes: 𝑓 0.58 ( 25694 hom., cov: 32)
Exomes 𝑓: 0.57 ( 234408 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

1
2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.266

Publications

47 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024514198).
BP6
Variant 2-210591913-A-G is Benign according to our data. Variant chr2-210591913-A-G is described in ClinVar as Benign. ClinVar VariationId is 128849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.1030A>Gp.Thr344Ala
missense
Exon 10 of 38NP_001866.2
CPS1
NM_001369256.1
c.1063A>Gp.Thr355Ala
missense
Exon 11 of 39NP_001356185.1
CPS1
NM_001122633.3
c.1030A>Gp.Thr344Ala
missense
Exon 11 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.1030A>Gp.Thr344Ala
missense
Exon 10 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.1048A>Gp.Thr350Ala
missense
Exon 11 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000881564.1
c.1030A>Gp.Thr344Ala
missense
Exon 10 of 38ENSP00000551623.1

Frequencies

GnomAD3 genomes
AF:
0.581
AC:
87841
AN:
151172
Hom.:
25660
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.612
Gnomad AMI
AF:
0.456
Gnomad AMR
AF:
0.526
Gnomad ASJ
AF:
0.614
Gnomad EAS
AF:
0.567
Gnomad SAS
AF:
0.615
Gnomad FIN
AF:
0.637
Gnomad MID
AF:
0.640
Gnomad NFE
AF:
0.564
Gnomad OTH
AF:
0.580
GnomAD2 exomes
AF:
0.567
AC:
141566
AN:
249584
AF XY:
0.573
show subpopulations
Gnomad AFR exome
AF:
0.613
Gnomad AMR exome
AF:
0.471
Gnomad ASJ exome
AF:
0.618
Gnomad EAS exome
AF:
0.548
Gnomad FIN exome
AF:
0.634
Gnomad NFE exome
AF:
0.566
Gnomad OTH exome
AF:
0.579
GnomAD4 exome
AF:
0.565
AC:
824785
AN:
1458762
Hom.:
234408
Cov.:
43
AF XY:
0.568
AC XY:
412380
AN XY:
725774
show subpopulations
African (AFR)
AF:
0.621
AC:
20719
AN:
33352
American (AMR)
AF:
0.480
AC:
21388
AN:
44526
Ashkenazi Jewish (ASJ)
AF:
0.608
AC:
15853
AN:
26058
East Asian (EAS)
AF:
0.551
AC:
21833
AN:
39626
South Asian (SAS)
AF:
0.605
AC:
52145
AN:
86150
European-Finnish (FIN)
AF:
0.627
AC:
33325
AN:
53180
Middle Eastern (MID)
AF:
0.649
AC:
3733
AN:
5750
European-Non Finnish (NFE)
AF:
0.559
AC:
620790
AN:
1109916
Other (OTH)
AF:
0.581
AC:
34999
AN:
60204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
19834
39667
59501
79334
99168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17366
34732
52098
69464
86830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.581
AC:
87924
AN:
151288
Hom.:
25694
Cov.:
32
AF XY:
0.583
AC XY:
43100
AN XY:
73866
show subpopulations
African (AFR)
AF:
0.613
AC:
25288
AN:
41252
American (AMR)
AF:
0.526
AC:
7976
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.614
AC:
2124
AN:
3458
East Asian (EAS)
AF:
0.567
AC:
2894
AN:
5106
South Asian (SAS)
AF:
0.616
AC:
2961
AN:
4810
European-Finnish (FIN)
AF:
0.637
AC:
6662
AN:
10462
Middle Eastern (MID)
AF:
0.644
AC:
188
AN:
292
European-Non Finnish (NFE)
AF:
0.564
AC:
38188
AN:
67714
Other (OTH)
AF:
0.582
AC:
1228
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1869
3738
5607
7476
9345
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.567
Hom.:
66075
Bravo
AF:
0.579
TwinsUK
AF:
0.565
AC:
2094
ALSPAC
AF:
0.556
AC:
2143
ESP6500AA
AF:
0.639
AC:
2815
ESP6500EA
AF:
0.568
AC:
4881
ExAC
AF:
0.568
AC:
68907
EpiCase
AF:
0.574
EpiControl
AF:
0.579

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Congenital hyperammonemia, type I (6)
-
-
6
not specified (6)
-
-
2
not provided (2)
-
-
1
Pulmonary hypertension, neonatal, susceptibility to;C4082171:Congenital hyperammonemia, type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
5.9
DANN
Benign
0.92
DEOGEN2
Pathogenic
0.83
D
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.042
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.5
L
PhyloP100
0.27
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.25
Sift
Benign
0.067
T
Sift4G
Uncertain
0.036
D
Polyphen
0.0010
B
Vest4
0.12
MPC
0.22
ClinPred
0.0075
T
GERP RS
-0.92
Varity_R
0.40
gMVP
0.31
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047883; hg19: chr2-211456637; COSMIC: COSV51811490; COSMIC: COSV51811490; API